US Biosimilars Market Is On A Solid Footing, 10 Years In
BIO 2020 Panelists Agree Momentum Is Building
Executive Summary
The market for biosimilars in the US appears to be improving, industry leaders said during a panel on biosimilars at the BIO 2020 digital meeting.